Afobazole Restores the Dopamine Level in a 6-Hydroxydopamine Model of Parkinson’s Disease
- Autores: Voronin M.V.1, Kadnikov I.A.1, Seredenin S.B.1
-
Afiliações:
- Zakusov Research Institute of Pharmacology
- Edição: Volume 13, Nº 1 (2019)
- Páginas: 49-56
- Seção: Experimental Articles
- URL: https://journals.rcsi.science/1819-7124/article/view/211639
- DOI: https://doi.org/10.1134/S1819712419010185
- ID: 211639
Citar
Resumo
In this study, 5 µg of 6-hydroxydopamine (6-OHDA) were injected unilaterally into the striatum of mice. The mice were then treated intraperitoneally with afobazole at a dose of 2.5 mg/kg for 14 days starting 30 min after the 6-OHDA injection. The content of monoamines was studied in the striatum of the mice. Afobazole prevented a decrease in the dopamine level in the 6-OHDA-damaged striatum of the experimental animals and did not affect the contents of norepinephrine, serotonin, or its metabolites in the striatum of both the control and 6-OHDA-treated mice.
Palavras-chave
Sobre autores
M. Voronin
Zakusov Research Institute of Pharmacology
Email: ikadnikov@gmail.com
Rússia, Moscow
I. Kadnikov
Zakusov Research Institute of Pharmacology
Autor responsável pela correspondência
Email: ikadnikov@gmail.com
Rússia, Moscow
S. Seredenin
Zakusov Research Institute of Pharmacology
Email: ikadnikov@gmail.com
Rússia, Moscow
Arquivos suplementares
